Phaedra Dowell
Neurology · Overland Park, KSNPI 1437411725
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.9% of the total across 244 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,407 and has fallen 99.2% since, to $20 in 2024.
Across 244 payments — averaging $13.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$366
- Novartis$217
- UCB, Inc.$215
- Acadia Pharmaceuticals Inc$202
- Acorda Therapeutics, Inc$191
- AbbVie$182
- plus $2K from 33 others
What the payments were for
- Speaking & faculty fees$1916%
- Food & beverage$3,07894%
- Education$100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 54 | $366 |
| Novartis | 15 | $217 |
| UCB, Inc. | 15 | $215 |
| Acadia Pharmaceuticals Inc | 19 | $202 |
| Acorda Therapeutics, Inc | 10 | $191 |
| AbbVie(2 entities) | 12 | $182 |
| AstraZeneca | 9 | $147 |
| Supernus Pharmaceuticals, Inc. | 9 | $145 |
| EMD Serono, Inc. | 9 | $136 |
| Neurocrine Biosciences, Inc. | 8 | $122 |
| Amneal Pharmaceuticals LLC | 9 | $118 |
| Amgen | 7 | $115 |
| Sanofi | 6 | $98 |
| Medtronic(2 entities) | 2 | $94 |
| Lilly USA, LLC | 7 | $94 |
| Biogen | 4 | $72 |
| Aquestive Therapeutics, Inc. | 3 | $55 |
| GRT US Holding, Inc. | 3 | $51 |
| Upsher-smith Laboratories LLC | 2 | $48 |
| Kyowa Kirin, Inc. | 3 | $46 |
| Promius Pharma LLC | 2 | $42 |
| Adamas Pharmaceuticals, Inc. | 3 | $42 |
| MDD US Operations, LLC | 3 | $42 |
| Sunovion Pharmaceuticals Inc. | 3 | $41 |
| Zyla Life Sciences, Inc. | 3 | $39 |
| Greenwich Biosciences, Inc. | 1 | $38 |
| Genentech USA, Inc. | 2 | $35 |
| Abbott | 2 | $33 |
| Livanova USA, Inc. | 2 | $29 |
| Lundbeck LLC | 2 | $29 |
| Eisai Inc. | 2 | $26 |
| CSL Behring | 1 | $26 |
| Assertio Therapeutics, Inc. | 2 | $26 |
| GE HealthCare | 1 | $25 |
| Arbor Pharmaceuticals, Inc. | 2 | $25 |
| Boston Scientific | 2 | $25 |
| Grifols USA, LLC | 1 | $19 |
| Mallinckrodt Enterprises LLC | 1 | $12 |
| Travere Therapeutics, Inc. | 3 | $10 |
How this compares
$3,278 in reported general payments places this provider in the 65th percentile of 131 neurology providers in Kansas.
Other neurology in Overland Park
- Stacy YoungerOverland Park$22K
- David ClarkOverland Park$22K
- John SeeleyOverland Park$11K
- Laura ReillyOverland Park$5K
- Ivan OsorioKansas City$101.7M
- Jeffrey KaplanLenexa$1.9M
- Rajesh PahwaKansas City$889K
- Sheetal MalikTopeka$137K
- Richard DubinskyKansas City$122K
- Barbara Jean OttleyHays$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.